GLPwatch

Effect of Liraglutide on endoplasmic reticulum stress in diabetes.

Biochem Biophys Res Commun · 2013

Last updated 2026-05-28

In lab tests, the diabetes drug liraglutide reduced stress in pancreatic cells by lowering activity in two specific stress-related pathways. In a mouse study, 8 weeks of liraglutide treatment decreased stress markers in the pancreas, but did not change insulin levels in the cells.

AI summary of the abstract below.

JournalBiochem Biophys Res Commun, 2013
Citations25
Relative citation ratio0.77
NIH percentile42
Molecules liraglutide
Conditions studied Type 2 Diabetes

Abstract

Endoplasmic reticulum (ER) stress is associated with the development of diabetes. The present study sought to investigate the effect of Liraglutide, a glucagon like peptide 1 analogue, on ER stress in β-cells. We found that Liraglutide protected the pancreatic INS-1 cells from thapsigargin-induced ER stress and the ER stress associated cell apoptosis, mainly by suppressing the PERK and IRE1 pathways. We further tested the effects of Liraglutide in the Akita mouse, an ER-stress induced type 1 diabetes model. After administration of Liraglutide for 8weeks, p-eIF2α and p-JNK were significantly decreased in the pancreas of the Akita mouse, while the treatment showed no significant impact on the levels of insulin of INS-cells. Taken together, our findings suggest that Liraglutide may protect pancreatic cells from ER stress and its related cell death.

Verbatim abstract via PubMed 24129189 ↗

Related research